https://www.marketscreener.com/news/latest/Merck-Completes-Enrolment-of-Evobrutinib-Phase-III-Clinical-Trials-Ahead-of-ECTRIMS-2021-36591243/?utm_source=telegram&utm_medium=social&utm_campaign=share